Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 3 (HNRNPA1P3)
- Target
- HNRNPA1P3
- Molecular classification
- Pseudogene, Related to RNA-binding proteins (as a non-functional homolog of heterogeneous nuclear ribonucleoproteins)
01
Overview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 3 (HNRNPA1P3) is a human processed pseudogene located in the genome that shares sequence homology with the functional heterogeneous nuclear ribonucleoprotein A1 gene but does not produce an active protein. Pseudogenes such as HNRNPA1P3 are typically the result of gene duplication or retrotransposition events that have rendered the gene nonfunctional through accumulating frameshifts or premature stop codons. HNRNPA1P3 is not known to have any protein-coding capacity, regulatory RNA function, or disease association, and its scientific and clinical relevance is primarily limited to its identity as a genetic relic rather than as a molecular target
- Other names
- HNRNPA1P3HNRPA1P3dJ447F3.1
02
Mechanism of action
None. No mechanism of action for drugs, as this gene is not a targetable protein
03
Biological functions
Generally none (non-protein-coding). As a pseudogene, HNRNPA1P3 does not encode a protein and is not known to have regulatory RNA function or involvement in cellular pathwaysPseudogenes may in rare cases act as competing endogenous RNAs or influence gene expression, but no evidence exists for HNRNPA1P3 having such a function
04
Disease associations
None established. Pseudogenes occasionally play roles in cancer and other diseases by affecting gene regulation, but no literature supports a disease role for HNRNPA1P3 specifically
05
Safety considerations
None. As a nonfunctional pseudogene without a known biological function or disease role, HNRNPA1P3 poses no documented safety or therapeutic challenges
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 3 (HNRNPA1P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 3 (HNRNPA1P3).